• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Macro-TSH: A Diagnostic Challenge.巨泌乳素:一项诊断挑战。
Eur Thyroid J. 2021 Mar;10(1):93-97. doi: 10.1159/000509184. Epub 2020 Aug 21.
2
Anti-ruthenium antibodies mimic macro-TSH in electrochemiluminescent immunoassay.抗钌抗体在电化学发光免疫分析中模拟大分子促甲状腺激素。
Clin Chem Lab Med. 2014 Nov;52(11):1589-94. doi: 10.1515/cclm-2014-0067.
3
Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH.由于大分子促甲状腺激素导致促甲状腺激素(TSH)水平假性升高。
Endocr J. 2009;56(3):435-40. doi: 10.1507/endocrj.k08e-361. Epub 2009 Apr 1.
4
Unexplained high thyroid stimulating hormone: a "BIG" problem.不明原因的促甲状腺激素升高:一个“重大”问题。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.01.2009.1474. Epub 2009 Apr 14.
5
Elevated thyroid-stimulating hormone level in a euthyroid neonate caused by macro thyrotropin-IgG complex.甲状腺刺激激素水平在甲状腺功能正常的新生儿中升高,是由大促甲状腺激素-IgG 复合物引起的。
Acta Paediatr. 2011 Sep;100(9):e135-7. doi: 10.1111/j.1651-2227.2011.02212.x. Epub 2011 Mar 7.
6
[Studies on patients with a discrepancy between free thyroid hormones and thyrotropin values].[游离甲状腺激素与促甲状腺激素值存在差异的患者研究]
Nihon Naibunpi Gakkai Zasshi. 1994 Aug 20;70(6):563-72. doi: 10.1507/endocrine1927.70.6_563.
7
Familial Dysalbuminemic Hyperthyroxinemia as a Cause for Discordant Thyroid Function Tests.家族性白蛋白异常血症性甲状腺素血症作为甲状腺功能检查结果不一致的一个原因
J Endocr Soc. 2021 Feb 1;5(4):bvab012. doi: 10.1210/jendso/bvab012. eCollection 2021 Apr 1.
8
Variability in the detection of macro TSH in different immunoassay systems.不同免疫分析系统检测到的宏观 TSH 存在差异。
Eur J Endocrinol. 2016 Jan;174(1):9-15. doi: 10.1530/EJE-15-0883. Epub 2015 Oct 5.
9
Macro-TSH: An Uncommon Explanation for Persistent TSH Elevation That Thyroidologists Have to Keep in Mind.大分子促甲状腺激素:甲状腺专家必须牢记的持续性促甲状腺激素升高的一种罕见原因。
J Pers Med. 2023 Oct 8;13(10):1471. doi: 10.3390/jpm13101471.
10
Macro-thyrotropin: a case report and review of literature.巨促甲状腺激素:病例报告及文献复习。
J Clin Endocrinol Metab. 2012 Jun;97(6):1823-8. doi: 10.1210/jc.2011-3490. Epub 2012 Mar 30.

引用本文的文献

1
MacroTSH: still a big problem for clinicians and clinical biochemists: lessons from a case report.促甲状腺激素(MacroTSH):临床医生和临床生物化学家的一个大问题:病例报告带来的启示。
Eur Thyroid J. 2024 May 9;13(3). doi: 10.1530/ETJ-24-0013. Print 2024 Jun 1.
2
Macro-TSH: An Uncommon Explanation for Persistent TSH Elevation That Thyroidologists Have to Keep in Mind.大分子促甲状腺激素:甲状腺专家必须牢记的持续性促甲状腺激素升高的一种罕见原因。
J Pers Med. 2023 Oct 8;13(10):1471. doi: 10.3390/jpm13101471.
3
Polyethylene glycol thyroid-stimulating hormone (PEG-TSH) testing in the management of pediatric thyroid dysfunction.聚乙二醇促甲状腺激素(PEG-TSH)检测在儿科甲状腺功能障碍管理中的应用。
Endocrine. 2024 May;84(2):524-532. doi: 10.1007/s12020-023-03575-5. Epub 2023 Oct 26.
4
Pars Distalis and Pars Tuberalis Thyroid-Stimulating Hormones and Their Roles in Macro-Thyroid-Stimulating Hormone Formation.垂体前叶和垂体柄促甲状腺激素及其在大促甲状腺激素形成中的作用。
Int J Mol Sci. 2023 Jul 20;24(14):11699. doi: 10.3390/ijms241411699.
5
Unexplained Hyperthyrotropinemia: A Biochemical and Clinical Challenge.不明原因的促甲状腺激素血症:一项生化与临床挑战。
J Clin Med. 2023 Apr 18;12(8):2934. doi: 10.3390/jcm12082934.
6
Age-related variation in thyroid function - a narrative review highlighting important implications for research and clinical practice.甲状腺功能的年龄相关变化——一项叙述性综述,强调对研究和临床实践的重要意义。
Thyroid Res. 2023 Apr 3;16(1):7. doi: 10.1186/s13044-023-00149-5.
7
Macro-PTH, a rare cause of unexplained elevated serum PTH levels.大分子甲状旁腺激素,是血清甲状旁腺激素水平不明原因升高的罕见原因。
J Endocrinol Invest. 2023 May;46(5):1039-1040. doi: 10.1007/s40618-023-02049-9. Epub 2023 Mar 2.
8
A Case of macro-TSH masquerading as subclinical hypothyroidism.一例伪装为亚临床甲状腺功能减退症的大 TSH 病例。
BMJ Case Rep. 2021 Jul 12;14(7):e243436. doi: 10.1136/bcr-2021-243436.

本文引用的文献

1
The Thyrotropin Receptor Mutation Database Update.促甲状腺激素受体突变数据库更新。
Thyroid. 2020 Jun;30(6):931-935. doi: 10.1089/thy.2019.0807. Epub 2020 Apr 1.
2
Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm.甲状腺功能免疫测定的干扰:临床意义和检测算法。
Endocr Rev. 2018 Oct 1;39(5):830-850. doi: 10.1210/er.2018-00119.
3
Current Thyrotropin Immunoassays Recognize Macro-Thyrotropin Leading to Hyperthyrotropinemia in Females of Reproductive Age.当前的促甲状腺激素免疫测定法可识别大促甲状腺激素,导致育龄女性出现促甲状腺激素血症。
Thyroid. 2018 Oct;28(10):1252-1260. doi: 10.1089/thy.2017.0624. Epub 2018 Aug 2.
4
Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia.血清催乳素再探讨:用于鉴别高催乳素血症和大分子催乳素血症的基于聚乙二醇沉淀法的参数参考区间及跨平台评估
Clin Chem Lab Med. 2017 Oct 26;55(11):1744-1753. doi: 10.1515/cclm-2016-0902.
5
Anti-Thyrotropin Autoantibodies in Patients with Macro-Thyrotropin and Long-Term Changes in Macro-Thyrotropin and Serum Thyrotropin Levels.大促甲状腺素患者中的抗促甲状腺素自身抗体以及大促甲状腺素和血清促甲状腺素水平的长期变化
Thyroid. 2017 Feb;27(2):138-146. doi: 10.1089/thy.2016.0442. Epub 2016 Dec 15.
6
Variability in the detection of macro TSH in different immunoassay systems.不同免疫分析系统检测到的宏观 TSH 存在差异。
Eur J Endocrinol. 2016 Jan;174(1):9-15. doi: 10.1530/EJE-15-0883. Epub 2015 Oct 5.
7
Macro TSH in patients with subclinical hypothyroidism.亚临床甲状腺功能减退患者中的大分子促甲状腺激素
Clin Endocrinol (Oxf). 2015 Dec;83(6):923-30. doi: 10.1111/cen.12643. Epub 2014 Dec 19.
8
An immunoglobulin G complexed form of thyroid-stimulating hormone (macro thyroid-stimulating hormone) is a cause of elevated serum thyroid-stimulating hormone concentration.一种与免疫球蛋白 G 结合的促甲状腺激素(大促甲状腺激素)形式是导致血清促甲状腺激素浓度升高的原因。
Ann Clin Biochem. 2013 Sep;50(Pt 5):416-20. doi: 10.1177/0004563213476271. Epub 2013 Jul 4.
9
Macro-thyrotropin: a case report and review of literature.巨促甲状腺激素:病例报告及文献复习。
J Clin Endocrinol Metab. 2012 Jun;97(6):1823-8. doi: 10.1210/jc.2011-3490. Epub 2012 Mar 30.
10
Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients.成年患者中因抗促甲状腺激素抗体导致促甲状腺激素值假性升高。
Clin Chem Lab Med. 2009;47(5):604-6. doi: 10.1515/CCLM.2009.138.

巨泌乳素:一项诊断挑战。

Macro-TSH: A Diagnostic Challenge.

作者信息

Larsen Camilla Bøgelund, Petersen Eva Rabing Brix, Overgaard Martin, Bonnema Steen Joop

机构信息

Department of Endocrinology, Odense University Hospital, Odense, Denmark.

Department of Clinical Research, University of Southern Denmark, Odense, Denmark.

出版信息

Eur Thyroid J. 2021 Mar;10(1):93-97. doi: 10.1159/000509184. Epub 2020 Aug 21.

DOI:10.1159/000509184
PMID:33777825
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7983602/
Abstract

INTRODUCTION

Analytical problems should be considered in case of a discrepancy between the results of biochemical tests and the clinical findings. Macro-hormones often artefactually elevate biochemical tests.

CASE PRESENTATION

A young male was referred with persistently elevated TSH (148 mIU/L) measured by a sandwich electrochemiluminescence immunoassay, ECLIA (Cobas; Roche, Basel, Switzerland). The patient's complaints were unspecific, and he appeared clinically euthyroid. The plasma levels of free T4 and free T3 were within the normal range, thyroid autoantibodies were negative, and thyroid ultrasonography was normal. During a short trial of thyroid hormone substitution, the level of TSH decreased to near-normal levels, but hyperthyroid symptoms emerged. TSH analysed by a different immunoassay (Architect; Abbott, Chicago, IL, USA) yielded similar results. In addition, serial dilutions were performed showing linearity, without detection of heterophilic antibody interference. Gel filtration chromatography confirmed the presence of macro-TSH.

CONCLUSION

The patient harboured macro-TSH, which is a rare condition. The complex binding of TSH to other plasma proteins, most often immunoglobulins, results in elevated plasma TSH. However, the biologically active fraction of TSH is normal, reflected by clinical and biochemical euthyroidism.

摘要

引言

当生化检测结果与临床发现存在差异时,应考虑分析方面的问题。大分子激素常常会人为地使生化检测结果升高。

病例介绍

一名年轻男性因采用夹心电化学发光免疫分析法(ECLIA,Cobas;罗氏公司,瑞士巴塞尔)测得促甲状腺激素(TSH)持续升高(148 mIU/L)而前来就诊。患者的症状不具特异性,临床检查显示甲状腺功能正常。游离T4和游离T3的血浆水平在正常范围内,甲状腺自身抗体呈阴性,甲状腺超声检查也正常。在短期甲状腺激素替代治疗试验期间,TSH水平降至接近正常水平,但出现了甲状腺功能亢进症状。采用另一种免疫分析法(Architect;雅培公司,美国伊利诺伊州芝加哥)分析TSH,结果相似。此外,进行了系列稀释,显示呈线性,未检测到嗜异性抗体干扰。凝胶过滤色谱法证实存在大分子TSH。

结论

该患者存在大分子TSH,这是一种罕见情况。TSH与其他血浆蛋白(最常见的是免疫球蛋白)的复杂结合导致血浆TSH升高。然而,TSH的生物活性部分是正常的,这在临床和生化甲状腺功能正常中得以体现。